16,255
Total Claims
$2.2M
Drug Cost
1,907
Beneficiaries
$1,147
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-25%
Cost per patient vs peers
$1,147 vs $1,524 avg
-4%
Brand preference vs peers
13.1% vs 13.7% avg
Opioid Prescribing
0.1%
Opioid Rate
13
Opioid Claims
$66
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
87% generic
Brand: 2,135 claims · $1.8M
Generic: 14,120 claims · $401K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 733 | $748K |
| Sacubitril/Valsartan | 336 | $327K |
| Apixaban | 275 | $278K |
| Tirzepatide | 78 | $91K |
| Evolocumab | 103 | $74K |
| Dapagliflozin Propanediol | 54 | $62K |
| Empagliflozin | 42 | $44K |
| Ticagrelor | 52 | $39K |
| Bisoprolol Fumarate | 631 | $38K |
| Dronedarone Hcl | 14 | $25K |
| Atorvastatin Calcium | 1,391 | $23K |
| Semaglutide | 18 | $20K |
| Potassium Chloride | 550 | $17K |
| Amlodipine Besylate/Valsartan | 114 | $15K |
| Olmesartan/Hydrochlorothiazide | 277 | $15K |
Prescribing Profile
Patient Profile
73
Avg Age
56%
Female
1.42
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data